AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2022
Sep 15, 2022
31676_dirs_2022-09-14_b63bd8ee-c351-4306-8839-30edce3ed7d8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2022-09-12
Reporting Person: Davis Krista (N/A)
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3